期刊
CELL STEM CELL
卷 22, 期 6, 页码 879-+出版社
CELL PRESS
DOI: 10.1016/j.stem.2018.05.003
关键词
-
资金
- Austrian Science Fund (FWF) [P26303-B20]
- German Research Council (DFG) [HA 7723/1-1]
- New Frontiers Group award of the Austrian Academy of Sciences
- ERC Starting Grant (European Union's Horizon 2020 research and innovation program) [679146]
- [FWF-SFB F061 (F6102)]
- Austrian Science Fund (FWF) [P26303] Funding Source: Austrian Science Fund (FWF)
Hematopoietic stem cells (HSCs) sustain hematopoiesis throughout life. HSCs exit dormancy to restore hemostasis in response to stressful events, such as acute blood loss, and must return to a quiescent state to prevent their exhaustion and resulting bone marrow failure. HSC activation is driven in part through the phosphatidylinositol 3-kinase (PI3K)/AKT/mTORC1 signaling pathway, but less is known about the cell-intrinsic pathways that control HSC dormancy. Here, we delineate an ERK-dependent, rate-limiting feedback mechanism that controls HSC fitness and their re-entry into quiescence. We show that the MEK/ERK and PI3K pathways are synchronously activated in HSCs during emergency hematopoiesis and that feedback phosphorylation of MEK1 by activated ERK counterbalances AKT/mTORC1 activation. Genetic or chemical ablation of this feedback loop tilts the balance between HSC dormancy and activation, increasing differentiated cell output and accelerating HSC exhaustion. These results suggest that MEK inhibitors developed for cancer therapy may find additional utility in controlling HSC activation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据